CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
Recruiting · NCT07204561 · Interventional (participants receive a specific treatment) · Lead sponsor: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
View the official record on ClinicalTrials.gov →Interventions studied
CeraVe Moisturizing CreamGalenico
What this trial is about
This is an open-label, randomised, comparative, prospective, interventional study of a cosmetic product.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Subjects with clinically confirmed mild-to-moderate atopic dermatitis (AD), as defined by an Eczema Area and Severity Index (EASI) score of 1-21, whose lesions will clear after treatment with a steroid and who will experience at least a 90% reduction in their EASI score.
- \- Participants of any gender, aged 18 years or over, from any phototype or ethnic group.
- Participants must be willing and able to give informed consent to participate in the study.
Exclusion criteria
- Age \<18 years. Participants who are unwilling or unable to give informed consent to participate in the study.
- Receiving any systemic treatment for atopic dermatitis (AD), including corticosteroids, cyclosporine, any approved biologics or JAK inhibitors.
- Any dermatological disorder which, in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin characteristics (except AD).
Where it is running
1 location listed.
- Fondazione PTV - Policlinico Tor Vergata - Roma, RM, Italy